How many investments has BayMed Venture Partners made?

BayMed Venture Partners has 18 tracked investments, 1 of which have exited.

What stage does BayMed Venture Partners invest at?

BayMed Venture Partners invests at the Seed, Series A stages.

What sectors does BayMed Venture Partners focus on?

BayMed Venture Partners focuses on Digital Health, Healthtech, Medical Devices.

Where is BayMed Venture Partners located?

BayMed Venture Partners is headquartered in San Francisco, US.

Who does BayMed Venture Partners co-invest with?

BayMed Venture Partners most often shares deals with Band of Angels, Broadview Ventures, Inreach Ventures, among 33 tracked co-investors.

BayMed Venture Partners

Venture capital

San Francisco · Seed–Series A · 6 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into BayMed Venture Partners

Paths you didn't know you had: your email and LinkedIn already hold routes to the BayMed Venture Partners team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict

Investment thesis

BayMed Venture Partners focuses on maturing early-stage medical device and digital health companies addressing important unmet clinical needs. The firm seeks disruptive, differentiated innovation on a global scale, sourcing deals throughout North America and Israel through extensive industry relationships. It emphasizes deep clinical and operational expertise, acting as a hands-on partner to portfolio companies. Its methodology is results-driven and exit-focused, aiming to deliver value for portfolio companies, investment partners, and the broader healthcare system.

Invests inDigital Health Healthtech Medical Devices Israel North America San Francisco United States

Source: firm website, verified Sep 27, 2026.

Leave your own feedback

Stage

Seed–Series A

San Francisco, CA, US

Instruments

Equity

Founded

2020

Tracked investments

Acquisitions

Team · 6 people

from the firm's website & public directories

Gary Gershony· Founding General Partner· San Francisco, California, United Statesin

Physician and interventional cardiologist who founded and served as CMO for Vascular Solutions and AngioScore (acquired for a combined $1.3B). An experienced healthcare venture and angel investor and board member for early-stage medical device companies, holding 11 patents and having led over 50 clinical trials.

gary@baymedvp.com

Neil Meyer· Founding General Partner· San Francisco Bay Areain

Healthcare investor with over 20 years of experience at firms including Partner Fund Management, Citadel, and JPMorgan. He also led investor relations and strategic finance at Thoratec Corporation prior to its $3.4B acquisition by St. Jude Medical, and has served on boards of early-stage medical device companies.

neil@baymedvp.com

Amanda White· Senior Associate

Medical device professional with over ten years of experience, including seven years at Edwards Lifesciences. A former Stanford Biodesign Innovation Fellow and Life Science Angels investment fellow, she currently serves as Senior Manager of Clinical Engineering at NC8. She holds degrees in biomedical engineering and economics from Duke University.

Gregg W. Stone· Advisor and clinical key opinion leader

Dr. Stone is a globally recognized leader in medical device technology development, Director of the TCT symposium, and Professor of Medicine at Mount Sinai Heart Health System. He has been principal investigator on more than 120 randomized clinical trials.

Leslie Saxon· Advisor and digital health key opinion leader

Dr. Saxon is Executive Director of the USC Center for Body Computing, a cardiac electrophysiologist, professor, and digital health expert with over 200 peer-reviewed publications. She is a frequent speaker at CES, TEDMED, and SXSW and a recipient of numerous awards.

Martin T. Rothman· Advisor and industry key opinion leader

Dr. Rothman is the former Chief Medical Officer for cardiovascular at Medtronic, co-founder of the British Cardiovascular Intervention Society, and Professor of Interventional Cardiology at Barts Health in London. He is a named inventor on more than 140 patents and an experienced venture partner.

What they invest in

from 14 of 18 portfolio companies

Healthtech ×12Medical Devices ×9Hardware ×5Biotech ×4Digital Health ×4Deep Tech ×2AI & Machine Learning ×1Enterprise Software ×1

HQs:United States×6Israel×2

Investments · 18 tracked

founders shown can be your intro path

By year:2022 · 2 2018 · 2 2014 · 15 dated

Deep Bluedeepbluemedical.com in 𝕏✓ verified

Deep Blue Medical Advances develops surgical devices and solutions to improve abdominal surgical processes and patient outcomes.

HealthtechMedical Devices

Howard Levinson(Inventor/Founder, Chief Medical Officer, Director)

Co-investorsBand of Angels Duke Capital Partners Medblue Wolfpack Investor Network

Append Medicalappendmedical.com in

Append Medical develops a transcatheter system using vacuum-based technology to treat non-valvular atrial fibrillation by occluding the left atrial appendage without implanting a device in the heart.

Deep TechHealthtechMedical DevicesOr Yehuda, IL

Leonid Sternik(MD, Inventor and cardiac surgeon)Zachi Berger(Founder and Observer)in Nadav Agian(CEO)in

Co-investorsALIVE Israel HealthTech Fund Shoni Health Ventures

AtaCor Medicalatacor.com

AtaCor Medical develops extravascular lead systems for cardiac rhythm management, including a novel extravascular defibrillation lead for EV-ICD therapy and an implantable, extracardiac pacemaker.

HardwareHealthtechMedical Devices

Alan(Co-founder & Vice President of Clinical, Regulatory & Quality)

Co-investorsArboretum Ventures Broadview Ventures Catalyst Health Ventures Hatteras Venture Partners

Cardiosensecardiosense.com in 𝕏Nov 2022

Cardiosense develops wearable sensing hardware and deep-learning algorithms that convert physiological signals into clinical insights for cardiovascular disease detection and management.

AI & Machine LearningDigital HealthHealthtechMedical DevicesChicago, US

Amit Gupta(Co-founder, Advisor)inMozziyar Etemadi(Co-founder, Head of AI)Omer Inan(Co-founder, Chief Scientific Officer)in Andrew Carek(Co-founder, Chief Technical Officer)in Eric Meizlish(Chief Executive Officer)in John D. Martin(Chief Medical Officer)in

Co-investorsBroadview Ventures Cross-Border Impact Ventures Laerdal Million Lives Fund OSF Ventures Portal Innovations Arboretum Ventures +1 more

Combinati Incorporatedcombinati.comMay 2018

Combinati developed the QuantStudio Absolute Q Digital PCR System, which uses microfluidic array plate (MAP) technology for detection and quantification of nucleic acids, rare mutations, and genome editing events.

BiotechDeep TechHardwarePalo Alto, US

Michael Mokelke(Director)Ju-Sung (Paul) Hung(Executive Officer, Director)Charles Collins(Director)

Co-investorsBand of Angels Endurance28 IT-Farm Corporation

Embolxembolx.com in 𝕏Oct 2022

Embolx is a commercial-stage medical device company developing microcatheters for arterial embolization procedures used to treat conditions such as cancerous tumors, benign prostatic hyperplasia, and uterine fibroids.

HardwareHealthtechMedical DevicesSunnyvale, US

Robert J.J. de Neve(Executive Officer, Director)Michael Allen(President & CEO)inNORMAN GITIS(Director)Paul Rogan(Director)FRANK GRILLO(Director)inTIANHONG XU(Director)

First Light Diagnosticsfirstlightdx.com in 𝕏

First Light Diagnostics develops the MultiPath benchtop analyzer, an instrument for rapid diagnostic testing.

BiotechHealthtechMedical Devices

Co-investorsBoston Harbor Angels LRVHealth 10X Venture Partners

Hillromhillrom.com in

Hillrom, now part of Baxter, develops connected medical devices and clinical systems for hospitals, physician offices, pharmacies and home care, including smart beds, vital signs monitors, infusion pumps, nurse call and communication systems, diagnostic and examination tools, respiratory and surgical technologies, and pharmaceuticals.

Digital HealthHealthtechMedical Devices

Landmark Gameslandmark.games in

Landmark Games develops games, as indicated by its branding and mission statement on the website.

Gaming

James Older(Founder)inDave Burpitt(Founder)in

Co-investorsInreach Ventures Moonfire Ventures RLC Ventures Vantage Capital Project A Ventures

Landmark Healthlandmarkhealth.org

Optum Care at Home provides in-home medical care and care navigation services for people enrolled in eligible health plans, including yearly in-home health visits, health screenings, and coordination of benefits like transportation and food assistance.

Digital HealthHealthtechHuntington Beach, US

Michael Huy Le, M.D.(Executive Officer)Adam Boehler(Executive Officer, Director)Eric Van Horn(Executive Officer)Elizabeth Haughton(Executive Officer)Carol De Vol(Executive Officer)Theodore Halkias(Executive Officer)

Co-investorsKhosla Ventures Wellington Management

Thermo Fisher Scientificthermofisher.com in 𝕏Feb 2014Acquired

Thermo Fisher provides life science products and laboratory equipment, including antibodies, consumables, biobanking resources, and Cryo-EM imaging systems for research labs and scientists.

BiotechEnterprise SoftwareHardwareHealthtechWaltham, US

Anthony Uzzo(Executive Officer, Director)inJoshua Geballe(Executive Officer, Director)James Gregory(Executive Officer, Director)Marc N. Casper(Executive Officer, Director)inAndrew J. Thomson(Executive Officer)Peter M. Wilver(Executive Officer)

Co-investorsARCH Venture Partners Cross Creek Advisors Eric F. Thiessen Excel Venture Management Heran Partners Highsage Ventures +7 more

Trisol Medicaltrisol-medical.com in

Trisol Medical develops a transcatheter tricuspid valve replacement device, using a nitinol frame with a dome-shaped leaflet, to treat severe tricuspid regurgitation while preserving right ventricle function.

HardwareHealthtechMedical DevicesYokneam, IL

Mordehay Vaturi(Inventor & Medical Director)inRon Davidson(CEO)inEli Ben-Hamou(VP R&D)Anat Kaufman(VP Regulatory)in

BoardShimon Eckhouse(Chairman)

Valfixmedvalfixmed.comAug 2018

VALFIX develops a transcatheter mitral valve repair system with a robotic interface, designed to convert open-heart valve surgery into a minimally invasive transcatheter procedure.

BiotechHealthtechMedical DevicesRoboticsTel Aviv-Yafo

Philip Lavin(Director)Elad Yaacoby(Director)Eli Bar(Executive Officer, Director)

Board Gary Gershony(Director)in

Vitaltechvitaltech.com in 𝕏

VitalTech develops solutions for virtual care delivery that optimize performance across the healthcare continuum for clients and their patients.

Digital HealthHealthtechSaaS

Co-investorsStanley Ventures

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Apend MedicalBreatheFirst LightValfix

Portfolio news

latest coverage across their companies

Trysignalbase

Deep Blue · trysignalbase.com · Apr 22, 2026

Frequently asked questions

How many investments has BayMed Venture Partners made?: BayMed Venture Partners has 18 tracked investments, 1 of which have exited.
What stage does BayMed Venture Partners invest at?: BayMed Venture Partners invests at the Seed, Series A stages.
What sectors does BayMed Venture Partners focus on?: BayMed Venture Partners focuses on Digital Health, Healthtech, Medical Devices.
Where is BayMed Venture Partners located?: BayMed Venture Partners is headquartered in San Francisco, US.
Who does BayMed Venture Partners co-invest with?: BayMed Venture Partners most often shares deals with Band of Angels, Broadview Ventures, Inreach Ventures, among 33 tracked co-investors.

Similar investors

Amadeus Capital Partners

Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.

$50K – $12.7M

B Capital Group

B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.

$10M – $50M

Breyer Capital

Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.

$500K – $10M

Canaan Partners

Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.

$500K – $20M

Capricorn Venture Partners

Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.

$270K – $10.8M